基库奇-富士本病:研究全面的临床病理特征和复发风险因素
Midori Filiz Nishimura1, Chikako Sakao1, Yuka Kurokawa1
1Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan.
Histopathology
|February 17, 2025
概括
复发的Kikuchi-Fujimoto病 (KFD) 与较低的C4补充水平和较高的抗核抗体 (ANA) 率有关. 这些发现表明,复发性KFD可能代表过渡性疾病和明显的自身免疫性疾病之间的中间阶段.
科学领域:
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
- 类风湿病学 类风湿病学
背景情况:
- 基库奇-富士门氏病 (KFD) 是一种罕见的,自我限制的疾病,其特征是发烧和宫淋巴腺症.
- 对于KFD复发的风险因素及其临床病理相关性仍然不太了解.
研究的目的:
- 调查与基库奇-富士门氏病复发相关的临床病理特征和危险因素.
- 探索血清学标记,组织学模式和KFD患者的疾病过程之间的关系.
主要方法:
- 对112名KFD患者的分析,重点关注人口统计数据,临床表现和实验室发现.
- 淋巴结活检的组织病理学分类,分为增殖性,死性和瘤性模式.
- 复发与C4补充水平,抗核抗体 (ANA) 状态和CD4+淋巴细胞计数的相关性.
主要成果:
- 在可用随访数据的23%患者中观察到复发.
- 较低的C4水平 (P=0.038) 和较高的ANA率 (P=0.007) 与KFD复发有显著的关联.
- 与增殖模式相比,死组织学模式与较大的淋巴结和较长的症状持续时间相关,CD4+淋巴细胞较少 (P<0.001).
结论:
- 低C4水平和阳性ANA是KFD复发的指标.
- 复发性KFD患者可能代表过渡性KFD和明显的自身免疫性疾病之间的中间状态.
- 临床病理学发现有助于理解KFD病变发生和预测临床结果.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
166
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
166
Inflammatory Bowel Disease I: Ulcerative Colitis
122
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
122
Chronic Bowel Disorders: Introduction
380
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
380
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
113
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
113
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K


